跳至主要内容
临床试验/NCT04210921
NCT04210921Unknown不适用

Clinical Efficacy of Acupuncture in the Treatment of Temporomandibular Disorders(TMD)

Beijing Hospital of Traditional Chinese Medicine1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2019年4月1日最近更新:
适应症

试验速览

阶段
不适用
入组人数
60
试验地点
1
主要终点
Visual analogue scale(VAS)

研究概览

简要总结

This is a single-blinded, randomized controlled trial to explore the effectiveness of acupuncture in the treatment of the pain due to TMD using the latest diagnostic criteria combined with subjective and objective indexes.

详细描述

This is a single-blinded, randomized controlled clinical trial. A total of 60 participants will be randomly assigned to two different groups. The treatment group will receive acupuncture with real penetration of the needle, while participants in the control group will be treated with the Park sham needle. All participants will be given for 4 weeks of treatment and 4 weeks of follow-up.The primary end-point is the reducing in intensity of pain due to TMD, which will be evaluated before treatment, 4 weeks after treatment and follow-up (4 weeks after treatment) by using 0-10 visual analogue score. Secondary end points include Graded Chronic Pain Scale Version 2.0(GCPS 2.0),Jaw Functional Limitations Scale - 20-item (JFLS-20),Depression, Anxiety and Stress Scales (DASS-21),Pittsburgh sleep quality index (PSQI),Pressure Pain Threshold (PPT),Surface electromyogram(sEMG).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Pain disorders in accordance with Diagnostic Criteria for Temporomandibular Disorders (DC/TMD)
  • Pain in the jaw, temple, in the ear, in front of ear or headache in the temple at any sides, and pain or headache modified (remission or aggravation) with movement at least 3 months.
  • Cooperated in completing the clinical trial successfully without language and mental disorders.

排除标准

  • Conditions that result in regional pain in temporomandibular joint.
  • Autoimmune diseases that result in regional pain in the temporomandibular joint.
  • Mental illness or substance abuse.
  • Pregnant women.

结局指标

主要结局

Visual analogue scale(VAS)

时间窗: Baseline,Week- 4(treatment period) and Week-8(follow-up period)

VAS is an international scale which reflects pain intensity and it has a 10-cm line ranging from 0 cm (no pain at all) to 10 cm (extremely painful). Pain intensity or pain relief in the tempormandibular joints will be measured by VAS. And then the investigators will compare the change of different time frames.The total score of this index is 10, and the better effect with the lower score.

次要结局

  • Surface electromyogram(sEMG)(Baseline and Week- 4(treatment period))
  • Jaw Functional Limitations Scale - 20-item (JFLS-20)(Baseline,Week- 4(treatment period) and Week-8(follow-up period))
  • Depression, Anxiety and Stress Scales (DASS-21)(Baseline,Week- 4(treatment period) and Week-8(follow-up period))
  • Graded Chronic Pain Scale Version 2.0(GCPS 2.0)(Baseline,Week- 4(treatment period) and Week-8(follow-up period))
  • Pressure Pain Threshold (PPT)(Baseline and Week- 4(treatment period))
  • Pittsburgh sleep quality index (PSQI)(Baseline,Week- 4(treatment period) and Week-8(follow-up period))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Li bin

Acupuncture director

Beijing Hospital of Traditional Chinese Medicine

研究点 (1)

Loading locations...

相似试验